XPH vs. ALC
XPH (SPDR S&P Pharmaceuticals ETF) is Health & Biotech Equities fund tracking the S&P Pharmaceuticals Select Industry Index, while ALC (Alcon Inc.) is a stock. Over the past 5 years, XPH returned 7.57%/yr vs -0.54%/yr for ALC. Their 0.46 correlation means their historical movements had little consistent relationship.
Performance
XPH vs. ALC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XPH achieves a 21.77% return, which is significantly higher than ALC's -11.56% return.
XPH
- 1D
- -2.41%
- 1M
- 1.34%
- 6M
- 23.05%
- YTD
- 21.77%
- 1Y
- 64.21%
- 3Y*
- 17.71%
- 5Y*
- 7.57%
- 10Y*
- 4.97%
- ALL TIME*
- 9.38%
ALC
- 1D
- -0.96%
- 1M
- -1.03%
- 6M
- -13.93%
- YTD
- -11.56%
- 1Y
- -20.68%
- 3Y*
- -5.58%
- 5Y*
- -0.54%
- 10Y*
- —
- ALL TIME*
- 2.81%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ALC Alcon Inc. | $158.18M | $157.97M | $154.82M |
| $6.19M | $7.25M | $5.32M |
XPH vs. ALC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XPH SPDR S&P Pharmaceuticals ETF | 21.77% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 8.67% |
ALC Alcon Inc. | -11.56% | -6.50% | 9.02% | 14.32% | -21.09% | 32.23% | 16.63% | -2.38% |
Correlation
The correlation between XPH and ALC is 0.36, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.36 |
Correlation (3Y) Balances recent behavior with more history. | 0.43 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.48 |
Correlation (All Time) Calculated using the full available price history since Apr 9, 2019 | 0.46 |
The correlation between XPH and ALC shifts across timeframes, from 0.36 (1 year) to 0.48 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XPH vs. ALC — Risk / Return Rank
XPH
ALC
XPH vs. ALC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and Alcon Inc. (ALC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XPH | ALC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.65 | ||
| Sortino ratioReturn per unit of downside risk | +4.66 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 0.89 | +0.57 |
| Calmar ratioReturn relative to maximum drawdown | 5.57 | -0.67 | +6.24 |
| Martin ratioReturn relative to average drawdown | 19.83 | -1.21 | +21.04 |
Loading charts...
Drawdowns
XPH vs. ALC - Drawdown Comparison
The maximum XPH drawdown since its inception was -48.03%, which is greater than ALC's maximum drawdown of -37.33%. Use the drawdown chart below to compare losses from any high point for XPH and ALC.
Loading charts...
Drawdown Indicators
| XPH | ALC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.03% | -37.33% | -10.70% |
Max Drawdown (1Y)Largest decline over 1 year | -11.97% | -30.42% | +18.45% |
Max Drawdown (3Y)Largest decline over 3 years | -23.57% | -37.33% | +13.76% |
Max Drawdown (5Y)Largest decline over 5 years | -30.92% | -37.33% | +6.41% |
Max Drawdown (10Y)Largest decline over 10 years | -35.97% | — | — |
Current DrawdownCurrent decline from peak | -2.84% | -30.34% | +27.50% |
Average DrawdownAverage peak-to-trough decline | -17.13% | -12.12% | -5.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.35% | 16.88% | -13.53% |
Volatility
XPH vs. ALC - Volatility Comparison
The current volatility for SPDR S&P Pharmaceuticals ETF (XPH) is 8.09%, while Alcon Inc. (ALC) has a volatility of 9.26%. This indicates that XPH experiences smaller price fluctuations and is considered to be less risky than ALC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XPH | ALC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.09% | 9.26% | -1.17% |
Volatility (6M)Calculated over the trailing 6-month period | 17.55% | 22.45% | -4.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.68% | 29.27% | -6.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.02% | 27.29% | -6.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.13% | 27.89% | -5.76% |
Dividends
XPH vs. ALC - Dividend Comparison
XPH's dividend yield for the trailing twelve months is around 0.49%, less than ALC's 1.17% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALC Alcon Inc. | 1.17% | 0.84% | 0.31% | 0.30% | 0.30% | 0.13% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XPH SPDR S&P Pharmaceuticals ETF | 0.49% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
XPH and ALC have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALC has higher volatility (9.26%) compared to XPH (8.09%). In terms of maximum drawdown, XPH dropped -48.03% vs ALC's -37.33%.
XPH currently has the higher Sharpe Ratio (2.95 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XPH and ALC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer